21563866|t|Aripiprazole and haloperidol in the treatment of delirium.
21563866|a|OBJECTIVE: To compare the efficacy and tolerability of aripiprazole and haloperidol in the amelioration of distressing symptoms of delirium and its motoric subtypes. METHODS: At Memorial Sloan-Kettering Cancer Center, we prospectively collected sociodemographic and medical data and systematically rated all patients diagnosed with delirium with the Memorial Delirium Assessment Scale (MDAS), Karnofsky Performance Scale (KPS) and the abbreviated Udvalg Kliniske Undersogelser Side Effect Rating Scale (UKU) at the initial diagnosis of delirium (T1), after 48-72 h (T2) and 7 days later (T3). All collected information was entered into a delirium database. For our analysis, we subsequently extracted data on aripiprazole (ARI) treated patients to compare to case-matched haloperidol (HAL) treated patients. RESULTS: We retrieved 21 patients treated with aripiprazole and 21 case-matched patients treated with haloperidol. Initial MDAS scores did not significantly differ between the groups. Over the course of treatment (T1 to T3), MDAS scores improved from 18.1 to 8.3 for ARI and 19.9 to 6.8 for HAL. The delirium resolution rate was 76.2% for ARI and 76.2% for HAL. For patients with hypoactive delirium, the MDAS scores improved from 15.6 to 5.7 for ARI and 18.8 to 8.1 for HAL. Delirium resolution rates for patients with hypoactive delirium were 100% for ARI and 77.8% for HAL. For patients experiencing hyperactive delirium, the MDAS scores improved from 19.9 to 6.8 for ARI and 20.8 to 5.8 for HAL. Delirium resolution rates for patients with hyperactive delirium were 58.3% for ARI and 75% for HAL. There were no significant differences in treatment results between ARI and HAL. Treatment with HAL caused more extrapyramidal side effects. CONCLUSION: From our secondary analysis, aripiprazole may be as effective as haloperidol in the management of delirium and its subtypes. Treatment with haloperidol resulted in more side effects.
21563866	0	12	Aripiprazole	Chemical	MESH:D000068180
21563866	17	28	haloperidol	Chemical	MESH:D006220
21563866	49	57	delirium	Disease	MESH:D003693
21563866	114	126	aripiprazole	Chemical	MESH:D000068180
21563866	131	142	haloperidol	Chemical	MESH:D006220
21563866	190	198	delirium	Disease	MESH:D003693
21563866	262	268	Cancer	Disease	MESH:D009369
21563866	367	375	patients	Species	9606
21563866	391	399	delirium	Disease	MESH:D003693
21563866	418	426	Delirium	Disease	MESH:D003693
21563866	595	603	delirium	Disease	MESH:D003693
21563866	697	705	delirium	Disease	MESH:D003693
21563866	768	780	aripiprazole	Chemical	MESH:D000068180
21563866	782	785	ARI	Chemical	MESH:D000068180
21563866	795	803	patients	Species	9606
21563866	831	842	haloperidol	Chemical	MESH:D006220
21563866	844	847	HAL	Chemical	MESH:D006220
21563866	857	865	patients	Species	9606
21563866	892	900	patients	Species	9606
21563866	914	926	aripiprazole	Chemical	MESH:D000068180
21563866	947	955	patients	Species	9606
21563866	969	980	haloperidol	Chemical	MESH:D006220
21563866	1134	1137	ARI	Chemical	MESH:D000068180
21563866	1158	1161	HAL	Chemical	MESH:D006220
21563866	1167	1175	delirium	Disease	MESH:D003693
21563866	1206	1209	ARI	Chemical	MESH:D000068180
21563866	1224	1227	HAL	Chemical	MESH:D006220
21563866	1233	1241	patients	Species	9606
21563866	1247	1266	hypoactive delirium	Disease	MESH:D003693
21563866	1314	1317	ARI	Chemical	MESH:D000068180
21563866	1338	1341	HAL	Chemical	MESH:D006220
21563866	1343	1351	Delirium	Disease	MESH:D003693
21563866	1373	1381	patients	Species	9606
21563866	1387	1406	hypoactive delirium	Disease	MESH:D003693
21563866	1421	1424	ARI	Chemical	MESH:D000068180
21563866	1439	1442	HAL	Chemical	MESH:D006220
21563866	1448	1456	patients	Species	9606
21563866	1470	1490	hyperactive delirium	Disease	MESH:D003693
21563866	1538	1541	ARI	Chemical	MESH:D000068180
21563866	1562	1565	HAL	Chemical	MESH:D006220
21563866	1567	1575	Delirium	Disease	MESH:D003693
21563866	1597	1605	patients	Species	9606
21563866	1611	1631	hyperactive delirium	Disease	MESH:D003693
21563866	1647	1650	ARI	Chemical	MESH:D000068180
21563866	1663	1666	HAL	Chemical	MESH:D006220
21563866	1735	1738	ARI	Chemical	MESH:D000068180
21563866	1743	1746	HAL	Chemical	MESH:D006220
21563866	1763	1766	HAL	Chemical	MESH:D006220
21563866	1849	1861	aripiprazole	Chemical	MESH:D000068180
21563866	1885	1896	haloperidol	Chemical	MESH:D006220
21563866	1918	1926	delirium	Disease	MESH:D003693
21563866	1960	1971	haloperidol	Chemical	MESH:D006220
21563866	Comparison	MESH:D000068180	MESH:D006220
21563866	Negative_Correlation	MESH:D000068180	MESH:D003693
21563866	Negative_Correlation	MESH:D006220	MESH:D003693

